Enhanced protein expression in mammalian cells using engineered SUMO fusions: Secreted phospholipase A 2

SUMOylation, the covalent attachment of SUMO (small ubiquitin‐like modifier), is a eukaryotic post‐translational event that has been demonstrated to play a critical role in several biological processes. When used as an N‐terminal tag or fusion partner, SUMO has been shown to enhance functional prote...

Full description

Saved in:
Bibliographic Details
Published in:Protein science 2008-09, Vol.17 (9), p.1586-1595
Main Authors: Peroutka, Raymond J., Elshourbagy, Nabil, Piech, Tara, Butt, Tauseef R.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SUMOylation, the covalent attachment of SUMO (small ubiquitin‐like modifier), is a eukaryotic post‐translational event that has been demonstrated to play a critical role in several biological processes. When used as an N‐terminal tag or fusion partner, SUMO has been shown to enhance functional protein production significantly by improving folding, solubility, and stability. We have engineered several SUMOs and, through their fusion, developed a system for enhancing the expression and secretion of complex proteins. To demonstrate the fidelity of this fusion technology, secreted phospholipase A 2 proteins (sPLA 2 ) were produced using HEK‐293T and CHO‐K1 cells. Five mouse sPLA 2 homologs were expressed and secreted in mammalian cell cultures using SUMO or SUMO‐derived, N‐terminal fusion partners. Mean and median increases of 43‐ and 18‐fold, respectively, were obtained using novel SUMO mutants that are resistant to digestion by endogenous deSUMOylases.
ISSN:0961-8368
1469-896X
DOI:10.1110/ps.035576.108